Center-Authored Papers

Filters: Author is Palanee-Phillips, Thesla  [Clear All Filters]
2015
Palanee-Phillips T, Schwartz K, Brown ER, Govender V, Mgodi N, Kiweewa FM, Nair G, Mhlanga F, Siva S, Bekker L-G et al..  2015.  Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.. PloS one. 10(6):e0128857. Abstract
Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje MZ, Bunge K, Ramjee G, Nair G, Palanee-Phillips T et al..  2015.  Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study.. The lancet HIV. 2(7):e279-e287. Abstract
Balkus JE, Nair G, Montgomery ET, Mishra A, Palanee-Phillips T, Ramjee G, Panchia R, Selepe P, Richardson BA, Chirenje ZM et al..  2015.  Age-Disparate Partnerships and Risk of HIV-1 Acquisition among South African Women Participating in the VOICE Trial.. Journal of acquired immune deficiency syndromes (1999). Abstract
2016
Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Kiweewa FM, Nair G, Mhlanga F et al..  2016.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.. The New England journal of medicine. Abstract
2017
Riddler SA, Husnik M, Ramjee G, Premrajh A, Tutshana BO, Pather A, Siva S, Jeenarain N, Nair G, Selepe P et al..  2017.  HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.. PloS one. 12(6):e0178594. Abstract
Husnik MJ, Brown ER, Marzinke M, Livant E, Palanee-Phillips T, Hendrix C, Kiweewa FM, Nair G, Soto-Torres LE, Schwartz K et al..  2017.  Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.. Journal of acquired immune deficiency syndromes (1999). Abstract
Balkus JE, Palanee-Phillips T, Reddy K, Siva S, Harkoo I, Nakabiito C, Kintu K, Nair G, Chappell C, Kiweewa FM et al..  2017.  Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception.. Journal of acquired immune deficiency syndromes (1999). Abstract